NO20025704L - Hygromycin A derivater for behandlingen av bakterielle og protozo-infeksjoner - Google Patents

Hygromycin A derivater for behandlingen av bakterielle og protozo-infeksjoner

Info

Publication number
NO20025704L
NO20025704L NO20025704A NO20025704A NO20025704L NO 20025704 L NO20025704 L NO 20025704L NO 20025704 A NO20025704 A NO 20025704A NO 20025704 A NO20025704 A NO 20025704A NO 20025704 L NO20025704 L NO 20025704L
Authority
NO
Norway
Prior art keywords
hygromycin
bacterial
derivatives
treatment
protozoal infections
Prior art date
Application number
NO20025704A
Other languages
English (en)
Other versions
NO20025704D0 (no
Inventor
Matthew Merrill Hayward
Ii Robert Gerald Linde
Takushi Kaneko
Mechael Visser
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20025704L publication Critical patent/NO20025704L/no
Publication of NO20025704D0 publication Critical patent/NO20025704D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20025704A 2000-06-02 2002-11-27 Hygromycin A derivater for behandlingen av bakterielle og protozo-infeksjoner NO20025704D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20902300P 2000-06-02 2000-06-02
PCT/IB2001/000946 WO2001092280A1 (en) 2000-06-02 2001-05-25 Hygromycin a derivatives for the treatment of bacterial and protozoal infections

Publications (2)

Publication Number Publication Date
NO20025704L true NO20025704L (no) 2002-11-27
NO20025704D0 NO20025704D0 (no) 2002-11-27

Family

ID=22777009

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025704A NO20025704D0 (no) 2000-06-02 2002-11-27 Hygromycin A derivater for behandlingen av bakterielle og protozo-infeksjoner

Country Status (31)

Country Link
US (1) US6867230B2 (no)
EP (1) EP1287011A1 (no)
JP (1) JP2003535100A (no)
KR (1) KR20030010655A (no)
CN (1) CN1432019A (no)
AP (1) AP2002002669A0 (no)
AR (1) AR028667A1 (no)
AU (1) AU2001260528A1 (no)
BG (1) BG107265A (no)
BR (1) BR0111242A (no)
CA (1) CA2410643A1 (no)
CZ (1) CZ20023859A3 (no)
EA (1) EA200201167A1 (no)
EC (1) ECSP014093A (no)
EE (1) EE200200671A (no)
GT (1) GT200100099A (no)
HU (1) HUP0302263A2 (no)
IL (1) IL152984A0 (no)
IS (1) IS6618A (no)
MA (1) MA26909A1 (no)
MX (1) MXPA02011966A (no)
NO (1) NO20025704D0 (no)
OA (1) OA12277A (no)
PA (1) PA8518101A1 (no)
PE (1) PE20020334A1 (no)
PL (1) PL359179A1 (no)
SK (1) SK16612002A3 (no)
SV (1) SV2002000474A (no)
TN (1) TNSN01080A1 (no)
UY (1) UY26741A1 (no)
WO (1) WO2001092280A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003097573A1 (en) 2002-05-16 2003-11-27 Sepracor, Inc. Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
CA3110075A1 (en) * 2018-08-20 2020-02-27 Northeastern University Hygromycin a compounds and methods of treating spirochete diseases
CU20180159A7 (es) * 2018-12-28 2020-10-20 Chengdu Olisynn Biotechnology Co Ltd Derivados de oligosacáridos sintéticos como vacuna contra la bordetella pertussis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1234567A (en) * 1915-09-14 1917-07-24 Edward J Quigley Soft collar.
US2004123A (en) * 1934-02-15 1935-06-11 Jr Robert B Loibl Pest exterminator
AU762302B2 (en) * 1998-05-04 2003-06-19 Pfizer Products Inc. 2"-deoxy hygromycin derivatives
GT199900064A (es) * 1998-05-04 2000-10-24 Pfizer Prod Inc Derivados de higromicina a.
EE200100301A (et) * 1998-12-02 2002-08-15 Pfizer Products Inc. Hügromütsiin A derivaadid kui antibakteriaalsed ühendid
HK1049672A1 (zh) * 1999-10-29 2003-05-23 辉瑞产品公司 潮霉素衍生物
US7654321B2 (en) * 2006-12-27 2010-02-02 Schlumberger Technology Corporation Formation fluid sampling apparatus and methods

Also Published As

Publication number Publication date
EE200200671A (et) 2004-08-16
SK16612002A3 (sk) 2004-04-06
AR028667A1 (es) 2003-05-21
WO2001092280A1 (en) 2001-12-06
IS6618A (is) 2002-11-14
HUP0302263A2 (hu) 2003-10-28
SV2002000474A (es) 2002-07-03
PE20020334A1 (es) 2002-04-30
CA2410643A1 (en) 2001-12-06
IL152984A0 (en) 2003-06-24
PA8518101A1 (es) 2002-09-17
BG107265A (bg) 2003-07-31
MXPA02011966A (es) 2003-04-22
US6867230B2 (en) 2005-03-15
TNSN01080A1 (fr) 2005-11-10
NO20025704D0 (no) 2002-11-27
PL359179A1 (en) 2004-08-23
UY26741A1 (es) 2001-12-28
US20030045528A1 (en) 2003-03-06
CN1432019A (zh) 2003-07-23
BR0111242A (pt) 2003-06-03
ECSP014093A (es) 2002-01-25
MA26909A1 (fr) 2004-12-20
CZ20023859A3 (cs) 2004-02-18
EP1287011A1 (en) 2003-03-05
EA200201167A1 (ru) 2003-06-26
KR20030010655A (ko) 2003-02-05
GT200100099A (es) 2002-01-31
OA12277A (en) 2006-05-11
JP2003535100A (ja) 2003-11-25
AU2001260528A1 (en) 2001-12-11
AP2002002669A0 (en) 2002-12-31

Similar Documents

Publication Publication Date Title
HK1049656A1 (zh) Fab i抑制剂
NO20013380D0 (no) 2-aminobenzoksazinonderivater for behandling av fedme
DE60041469D1 (de) Vorwärtskopplungsverstärker
NO20025204D0 (no) Forbindelser og fremgangsmÕter for behandling og forebygging av bakterielle infeksjoner
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
NO20005839D0 (no) Preparater for behandling av HIV og andre virale infeksjoner
PL376454A1 (en) 1-acyl-pyrrolidine derivatives for the treatment of viral infections
NO20031626L (no) Pyridonderivater for behandling av atherosklerose
NO20015464L (no) Attenuerte mikroorganismer for behandling av infeksjon
NO20014314L (no) Blandinger og metoder for behandling av stafylokokkisk infeksjon
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
MXPA03005097A (es) Proceso para el aislamiento y purificacion de epotilonas.
DE60124485D1 (de) Vorwärtskopplungsverstärker
PL356640A1 (en) Treatment of viral infections using levovirintm
EP1421061A4 (en) OXIME DERIVATIVES FOR THE TREATMENT OF DYSLIPIDEMIA AND HYPERCHOLESTEROLEMIA
NO20013651D0 (no) Anvendelse av fosfororganiske forbindelser for profylaktisk og terapeutisk behandling av infeksjoner
NO20025704L (no) Hygromycin A derivater for behandlingen av bakterielle og protozo-infeksjoner
NO20032769L (no) Kombinasjonsmetode for behandling av virale infeksjoner
GB9906569D0 (en) Detection of bacterial infection
NO20022949D0 (no) Attenuerte mikroorganismer for behandling av infeksjon
PL350128A1 (en) Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections
AU2001282277A1 (en) Treatment of mycobacterial infection
AU3524700A (en) Prevention and treatment of viral infections
AU1392601A (en) Prevention and treatment of biomaterial-associated infections

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application